4D Biomaterials secures £1.6m funding 4D Biomaterials, which has developed a new biomaterial used for 3D printing medical implants, has completed a £1.6m funding round. The inves…
NanoSyrinx raises £6.2m to develop its synthetic biology platform for targeted intracellular engineering Coventry, United Kingdom, 19th July 2021 – NanoSyrinx, a biotech company developing a new cell engineering tool for novel targeted therapeut…